Patents by Inventor John E. Dowling

John E. Dowling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods of treating retinal disease
    Patent number: 11724987
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: August 15, 2023
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20230041335
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Application
    Filed: September 1, 2022
    Publication date: February 9, 2023
    Inventors: Thomas A. JORDAN, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20210269402
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Application
    Filed: February 1, 2021
    Publication date: September 2, 2021
    Inventors: Thomas A. JORDAN, John E. DOWLING, John Clifford CHABALA
  • Compositions and methods of treating retinal disease
    Patent number: 10913722
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: February 9, 2021
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20190210971
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: January 7, 2019
    Publication date: July 11, 2019
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 10202348
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: January 3, 2018
    Date of Patent: February 12, 2019
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20180194733
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: January 3, 2018
    Publication date: July 12, 2018
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 9896419
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: February 20, 2018
    Assignee: ALDEYRA THERAPEUTICS, INC.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20170320829
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: April 14, 2017
    Publication date: November 9, 2017
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 9650342
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: May 16, 2017
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20160168098
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: February 22, 2016
    Publication date: June 16, 2016
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 9364471
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: June 14, 2016
    Assignee: ALDEYRA THERAPEUTICS, INC.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 9265759
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: February 23, 2016
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20150209345
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: December 23, 2014
    Publication date: July 30, 2015
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20150209333
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Application
    Filed: December 23, 2014
    Publication date: July 30, 2015
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 8940764
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: January 27, 2015
    Assignee: Aldexa Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 8940721
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: January 27, 2015
    Assignee: Aldexa Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and Methods of Treating Retinal Disease
    Publication number: 20110263645
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: July 1, 2011
    Publication date: October 27, 2011
    Applicant: Neuron Systems, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 7973025
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: July 5, 2011
    Assignee: Neuron Systems, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Publication number: 20090182009
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Application
    Filed: May 26, 2006
    Publication date: July 16, 2009
    Applicant: Neuron Systems, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala